CLB Core Laboratories Inc. /DE/
Oil & Gas Field Services, NEC · NYSE · SEC CIK 1958086 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-0.1%
TTM net income YoY-51.6%
TTM EPS YoY-50.0%
Revenue 3-yr CAGR0.5%
Net income 3-yr CAGR-27.7%
Margins
Gross margin19.1%
Operating margin7.5%
Net margin3.0%
FCF margin2.0%
EBITDA margin10.4%
Returns
ROE5.7%
ROA2.6%
ROIC (approx.)6.0%
Asset turnover0.88x
Leverage & solvency
Liabilities / assets52.1%
Debt / equity0.40x
Current ratio2.19x
Interest coverage3.50x
Cash quality & payout
Operating cash flow / net income1.59x
Accruals ratio-1.5%
Payout ratio11.9%
Capex / revenue2.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $526.52M | $523.85M |
| Cost of revenue | $417.59M | $420.52M |
| Gross profit | $108.93M | $103.33M |
| SG&A expense | $45.43M | $39.77M |
| Operating income | $56.47M | $58.56M |
| Interest expense | $10.57M | $12.37M |
| Pretax income | $45.90M | $46.19M |
| Income tax | $15.51M | $14.03M |
| Net income | $29.67M | $31.40M |
| EBITDA | $71.12M | $73.51M |
| EPS (basic) | 0.64 | 0.67 |
| EPS (diluted) | 0.63 | 0.66 |
| Dividends declared per share | 0.04 | 0.04 |
| Weighted avg. shares (diluted) | 47.03M | 47.69M |
| Balance sheet | ||
| Cash & equivalents | $22.70M | $19.16M |
| Receivables | $113.53M | $111.76M |
| Inventory | $54.50M | $59.40M |
| Current assets | $214.66M | $221.33M |
| PP&E, net | $99.45M | $97.06M |
| Goodwill | $105.79M | $99.44M |
| Intangibles | $7.12M | $6.40M |
| Total assets | $584.01M | $585.13M |
| Current liabilities | $106.02M | $102.44M |
| Long-term debt | $110.25M | $126.11M |
| Total debt | $110.25M | $126.11M |
| Total liabilities | $311.80M | $332.81M |
| Shareholders' equity | $265.99M | $246.57M |
| Net debt | $87.55M | $106.95M |
| Shares outstanding | 46.10M | 46.83M |
| Cash flow statement | ||
| Operating cash flow | $37.03M | $56.39M |
| Capital expenditure | $11.21M | $11.89M |
| Free cash flow | $25.82M | $44.50M |
| Investing cash flow | -$2.23M | -$6.39M |
| Financing cash flow | -$31.25M | -$45.96M |
| Depreciation & amortization | $14.65M | $14.95M |
| Stock-based compensation | $7.14M | $3.75M |
| Dividends paid | $1.87M | $1.88M |
| Share buybacks | $12.43M | $5.31M |
Free plan shows the latest 2 periods; Pro shows all 5 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.